CERN - Cerner Stock: An Undervalued Healthcare Dividend Growth Machine

• Even after taking on leverage last year to fund an acquisition, CERN's balance sheet remains very strong and flexible.
• The company has numerous competitive advantages which give it a durable moat.
• CERN has grown EPS at an impressive rate over the past decade and appears poised to continue growing at a brisk clip.
• Management initiated a dividend in 2019 and is growing it quickly alongside aggressive buybacks.
• Trading at a discount to historical multiples with a strong dividend growth outlook makes CERN an attractive risk-adjusted addition to our portfolio.

For further details see: